Your browser doesn't support javascript.
loading
Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis.
Akkerman, Onno W; Grasmeijer, Floris; de Lange, Wiel C M; Kerstjens, Huib A M; de Vries, Gerard; Bolhuis, Mathieu S; Alffenaar, Jan-Willem; Frijlink, Henderik W; Smith, Grace; Gajraj, Roger; de Zwaan, Rina; Hagedoorn, Paul; Dedicoat, Martin; van Soolingen, Dick; van der Werf, Tjip S.
Afiliação
  • Akkerman OW; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands o.w.akkerman@umcg.nl.
  • Grasmeijer F; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • de Lange WCM; Both authors contributed equally.
  • Kerstjens HAM; University of Groningen, Dept of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands.
  • de Vries G; Both authors contributed equally.
  • Bolhuis MS; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Alffenaar JW; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • Frijlink HW; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Smith G; KNCV Tuberculosis Foundation, Den Haag, The Netherlands.
  • Gajraj R; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • de Zwaan R; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Hagedoorn P; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Dedicoat M; University of Groningen, Dept of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands.
  • van Soolingen D; National Mycobacteriology Reference Unit, Birmingham, UK.
  • van der Werf TS; Public Health England, Birmingham, UK.
Eur Respir J ; 51(3)2018 03.
Article em En | MEDLINE | ID: mdl-29419442
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Extensivamente Resistente a Medicamentos Limite: Adult / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Extensivamente Resistente a Medicamentos Limite: Adult / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article